NBOCA’s policy is that data on colorectal cancer outcomes during the COVID-19 pandemic and the subsequent recovery phase will not be used for benchmarking or assessment of hospital trusts and MDTs.
The only NBOCA trust/MDT outcome which will be outlier reported in 2023 is risk-adjusted 2-year mortality in patients having surgery 1 Apr 2019 – 31 Mar 2020. 2-year mortality is an important indicator of the overall quality of care provided by a colorectal cancer MDT. Given the importance of this indicator we plan to begin reporting risk-adjusted 2-year mortality for patients having major surgery as the first indicator re-introduced following COVID-19 pandemic and recovery period.
Outlier reporting from 2024:
From 2024 reporting onwards, outlier reporting will resume for all of the NBOCA trust/MDT outcomes.